{"id":207836,"date":"2020-05-26T06:54:50","date_gmt":"2020-05-26T06:54:50","guid":{"rendered":"http:\/\/www.thetruthseeker.co.uk\/?p=207836"},"modified":"2020-05-30T06:37:51","modified_gmt":"2020-05-30T06:37:51","slug":"trump-appoints-big-pharma-exec-connected-to-bill-gates-to-head-vaccine-development","status":"publish","type":"post","link":"https:\/\/www.thetruthseeker.co.uk\/?p=207836","title":{"rendered":"Trump Appoints Exec Connected to Bill Gates to Head Vaccine Development"},"content":{"rendered":"

Derrick Broze \u2013 The Last American Vagabond May 15, 2020<\/strong><\/h1>\n

\"\"<\/a><\/p>\n

On Friday, Donald Trump announced his appointment of Moncef Slaoui, a former executive with vaccine manufacturer GlaxoSmithKline, to lead \u201cOperation Warp Speed\u201d, Trump\u2019s plan to fast track the development of vaccines for COVID-19. Slaoui will serve in a volunteer position, assisted by Army Gen. Gustave Perna, the commander of United States Army Materiel Command.<\/span><\/p>\n

According to the Trump administration, Operation Warp Speed program is focusing on four vaccines, with the hopes of testing and producing 100 million doses by October 2020, 200 million by December, and 300 million doses by January. At Friday\u2019s press conference, Slaoui said he believes the goal of vaccines by January 2021 is a \u201ccredible goal\u201d. Secretary of Defense Mark Esper was more adamant, stating that, \u201cwinning matters and we will deliver, by the end of this year, a vaccine\u201d.<\/span><\/p>\n

Operation Warp Speed and the calls for public-private partnerships mimic the National Institutes of Health\u2019s recent call for bringing together pharmaceutical companies to develop a vaccine for COVID-19. The NIH plan, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership<\/a><\/strong><\/span>, emphasizes \u201ca collaborative framework for prioritizing vaccine and drug candidates, streamlining clinical trials, coordinating regulatory processes and\/or leveraging assets among all partners to rapidly respond to the COVID-19 and future pandemics.\u201d<\/em><\/span><\/p>\n

The appointment of Slaoui follows previous statements regarding Trump\u2019s desire to have vaccines available to Americans by the fall. \u201cI think we\u2019re going to have a vaccine by the end of the year, and I think distribution will take place almost simultaneously because we\u2019ve geared up the military,\u201d<\/em> Trump said Thursday afternoon. Trump also told the Fox Business Network<\/strong><\/span><\/a> that because of the \u201cmassive job to give this vaccine\u201d<\/em> the military is now being mobilized. \u201cWe\u2019re going to be able to give it to a lot of people very, very rapidly,\u201d<\/em> Trump concluded.<\/span><\/p>\n

At Friday\u2019s press conference Trump said his team has been working 24 hours a day to develop treatments for COVID-19. Despite the heavy focus on vaccines, Trump did state that his administration is working on other treatments, including \u201ctherapeutics\u201d. \u201cIt\u2019s not solely vaccine based, other things have never had a vaccine and they go away. I don\u2019t people to think this is all dependent on a vaccine, but it would be tremendous,\u201d <\/em>Trump stated.<\/span><\/p>\n

However, the appointment of Dr. Slaoui is an indication that the Trump administration approves of the former executive\u2019s efforts to develop vaccines and his partnership with the Bill and Melinda Gates Foundation.<\/span><\/p>\n

Moncef Slaoui and the Bill and Melinda Gates Foundation<\/h3>\n

An examination of the career and connections of Dr. Moncef Slaoui reveals that Donald Trump\u2019s appointment of a Big Pharma executive is not a cause for celebration, but rather, another piece of the incestuous web connecting Bill and Melinda Gates and the Medical Mafia.<\/span><\/p>\n

Dr. Moncef Slaoui\u2019s official biography states:<\/span><\/p>\n

\u201cDr. Slaoui was a Professor of Immunology at the University of Mons, Belgium. He has authored more than 100 scientific papers and presentations. Dr. Slaoui earned a Ph.D. in Molecular Biology and Immunology from the University Libre de Bruxelles, Belgium and completed postdoctoral studies at Harvard Medical School and Tufts University School of Medicine, Boston.\u201d<\/span><\/p>\n

Following his education, Slaoui joined the pharmaceutical industry, serving on the board of Directors of GlaxoSmithKline between 2006 through 2015. Slaoui served in several senior research & development (R&D) roles with GlaxoSmithKline during his time with the company, including Chairman of Global Vaccines. GSK has a history of working with<\/strong><\/span><\/a> the Bill and Melinda Gates Foundation on projects such as the development of a malaria vaccine and anti-HIV compounds used as microbicides. In fact, Dr. Slaoui worked for 27 years on the malaria vaccine, ultimately partnering with the Bill and Melinda Gates Foundation to develop a $600 million malaria vaccine. When Slaoui took over at GSK, his predecessor, Tachi Yamada, joined the Bill and Melinda Gates Foundation.<\/span><\/p>\n

More recently, Slaoui sits on the boards of pharmaceutical companies and biotechnology organizations. He is also partner at MediciX investment firm<\/strong><\/span><\/a>, chairman of the board at Galvani Bioelectronics<\/a><\/strong><\/span>, chairman of the board at SutroVax<\/a> and sits on the boards of Artisan Biosciences<\/strong><\/span><\/a>, Human Vaccines Project and Moderna Therapeutics. Each of these companies is involved in vaccine development and the emerging field of bioelectronics.<\/span><\/p>\n

Galvani Bioelectronics was formed out of an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, and GSK. The goal is to \u201cenable the research, development and commercialisation of bioelectronic medicines.\u201d<\/span><\/p>\n

Bioelectronic medicine is a relatively new research field focused on tackling chronic diseases by using \u201cminiaturised, implantable devices that can modify electrical signals that pass along nerves in the body, including irregular or altered impulses that occur in many illnesses\u201d.<\/strong> GSK has been active in this field since 2012 and has stated that chronic conditions such as arthritis, diabetes and asthma could potentially be treated using these devices. GSK called the partnership<\/strong><\/span><\/a> an important step in their research of bioelectronics. GSK stated that if they are successful at using \u201cadvances in biology and technology\u201d to \u201ccorrect the irregular patterns found in disease states, using miniaturised devices attached to individual nerves\u201d, this method would be a \u201cnew therapeutic modality alongside traditional medicines and vaccines.\u201d<\/span><\/p>\n

Galvani\u2019s plan to use miniature implantable devices within the body was described by MIT Technology Review as \u201chacking the nervous system<\/strong><\/span><\/a>.\u201d In 2016, Slaoui said<\/strong><\/span><\/a>, \u201cWe hope to have approval and be in the marketplace in the next seven to 10 years. It\u2019s not science fiction. And it\u2019s progressing quite well.\u201d<\/em><\/span><\/p>\n

In 2016, Slaoui was appointed to the Board of Directors of Moderna Therapeutics<\/strong><\/span><\/a>, a biotech company that is leading the way for messenger RNA (mRNA) therapeutics and vaccines. TLAV writer Whitney Webb recently reported<\/a><\/strong><\/span> on Moderna Therapeutics\u00a0joining the fight against COVID-19:<\/span><\/p>\n

\u201cThe Coalition for Epidemic Preparedness Innovations (CEPI) announced that it would fund three separate programs in order to promote the development of a vaccine for the new coronavirus responsible for the current outbreak.<\/span><\/p>\n

CEPI \u2014 which describes itself as \u201ca partnership of public, private, philanthropic and civil organizations that will finance and co-ordinate the development of vaccines against high priority public health threats\u201d \u2014 was founded in 2017 by the governments of Norway and India along with the World Economic Forum and the Bill and Melinda Gates Foundation.<\/strong> Its massive funding and close connections to public, private and non-profit organizations have positioned it to be able to finance the rapid creation of vaccines and widely distribute them.<\/span><\/p>\n

CEPI\u2019s recent announcement revealed that it would fund two pharmaceutical companies \u2014 Inovio Pharmaceuticals and Moderna Inc. \u2014 as well as Australia\u2019s University of Queensland, which became a partner<\/a><\/strong><\/span> of CEPI early last year. Notably, the two pharmaceutical companies chosen have close ties to and\/or strategic partnerships with DARPA and are developing vaccines that controversially involve genetic material and\/or gene editing. The University of Queensland also has ties to DARPA, but those ties are not related to the university\u2019s biotechnology research, but instead engineering<\/span><\/a> and missile development<\/a><\/span>.\u201d<\/strong><\/span><\/p>\n

Webb goes on to detail how Moderna is working with the U.S. NIH to develop a vaccine for the new coronavirus and how the project will be entirely funded by CEPI, which in turn was founded and funded by the Bill and Melinda Gates Foundation. Moderna\u2019s vaccine is a controversial messenger RNA (mRNA) vaccine which was developed with a $25 million grant<\/a><\/strong><\/span> from the Defense Advanced Research Project Agency (DARPA<\/a><\/strong><\/span>).<\/span><\/p>\n

\u201cModerna\u2019s past and ongoing research efforts <\/em>have included<\/em><\/a><\/strong><\/span> developing mRNA vaccines tailored to an individual\u2019s unique DNA as well as an unsuccessful effort to create a mRNA vaccine for the Zika Virus, which was funded by the U.S. government,\u201d <\/em>Webb reported.<\/span><\/p>\n

To recap:<\/strong> Donald Trump has appointed Dr. Moncef Slaoui to head Operation Warp Speed, his effort to fast track the development of COVID-19 vaccines and other therapeutics. Slaoui has worked in the pharmaceutical industry on vaccine development for decades. Several companies he has worked with or sits on the Board of Directors are funded in part by the Bill and Melinda Gates Foundation. One of these companies, Moderna, is conducting research on RNA vaccines in partnership with the U.S. government\u2019s creepiest organization, DARPA.<\/span><\/p>\n

Once again, this should be an indication that Donald Trump is continuing to push the agenda of Big Pharma.<\/span> <\/strong><\/p>\n

Will the vaccine be mandatory?<\/h3>\n

Despite the launch of Operation Warp Speed, the appointment of a Big Pharma Executive, and the calls for military involvement in distribution of vaccines, some Trump supporters still maintain that Donald J. Trump is not a part of the Rockefeller-Gates agenda to vaccinate the entire world. However, Trump\u2019s action tell another story.<\/span><\/p>\n

Although Trump questioned the safety of vaccinations as far back as 2014, since becoming President he has towed the party line. In April 2019, while questioned about alleged outbreaks of measles and whether or not he supports Americans\u2019 right to opt out of the MMR vaccine, Trump stated<\/strong><\/span><\/a> that Americans \u201chave to get the shots. The vaccinations are so important.\u201d<\/em> Trump concluded with the support of mandatory vaccinations: \u201cThis is really going around now. They have to get their shots.\u201d<\/em><\/span><\/p>\n

We do acknowledge that Donald Trump has made several statements \u2013 including during Friday\u2019s press conference \u2013 indicating that he is not currently planning to call for mandatory vaccinations of all Americans. However, rather than hanging on the words of the president as if they are gospel, we should judge the man by his actions. When looking at Trump\u2019s actual actions \u2013 not his tweets \u2013 it\u2019s clear that he has not drained the swamp, but has instead, filled it with familiar Deep State bureaucrats pushing an agenda of their own. The individuals involved in this agenda do not have the best interests of Americans in mind.<\/span><\/p>\n

Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

When looking at Trump\u2019s actual actions \u2013 not his tweets \u2013 it\u2019s clear that he has not drained the swamp, but has instead, filled it with familiar Deep State bureaucrats<\/p>\n","protected":false},"author":39262,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[105],"tags":[],"class_list":["post-207836","post","type-post","status-publish","format-standard","hentry","category-coronavirus"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/207836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=\/wp\/v2\/users\/39262"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=207836"}],"version-history":[{"count":4,"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/207836\/revisions"}],"predecessor-version":[{"id":207868,"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/207836\/revisions\/207868"}],"wp:attachment":[{"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=207836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=207836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thetruthseeker.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=207836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}